BRAF(V600E) mutation and the biology of papillary thyroid cancer(545 views) Frasca F, Nucera C, Pellegriti G, Gangemi P, Attard M, Stella M, Loda M, Vella V, Giordano C, Trimarchi F, Mazzoni E, Belfiore A, Vigneri R
Endocr Relat Cancerendocrine Related Cancer (ISSN: 1351-0088), 2008; 15(1): 191-205.
Endocrinologia, Dipartimento di Medicina Interna e Medicina Specialistica, University of Catania, PO Garibaldi Nesima, Via Palermo 636, 95122 Catania, Italy
Dipartimento Clinico-Sperimentale di Medicina e Farmacologia, Azienda Ospedaliera Universitaria Policlinico, University of Messina, Via Consolare Valeria, 98122 Messina, Italy
Unità Operativa di Anatomia Patologica, Ospedale Vittorio Emanuele, Via Plebiscito 628, 95124 Catania, Italy
Divisione di Endocrinologia, Ospedale Cervello, 90146 Palermo, Italy
Servizio di Anatomia Patologica, Ospedale Cervello, Via Trabucco 180, 90146 Palermo, Italy
Pathology Department, Harvard Medical School, Brigham and Women's Hospital, 44 Binney Street, Boston, MA, United States
Sezione di Endocrinologia, Dipartimento di Oncologia Sperimentale Clinica, Policlinico, Via del Vespro 129, 90127 Palermo, Italy
Unit Operativa di Anatomia Patologica, Ospedale Vittorio Emanuele, Via Plebiscito 628, 95124 Catania, Italy
References: Abrosimov, A., Saenko, V., Rogounovitch, T., Namba, H., Lushnikov, E., Mitsutake, N., Yamashita, S., Different structural components of conventional papillary thyroid carcinoma display mostly identical BRAF status (2007) International Journal of Cancer, 120, pp. 196-20
Akslen, L.A., Haldorsen, T., Thoresen, S.O., Glattre, E., Incidence pattern of thyroid cancer in Norway: Influence of birth cohort and time period (1993) International Journal of Cancer, 53, pp. 183-187
Arnbjornsson, E., Arnbjornsson, A., Olafsson, A., Thyroid cancer incidence in relation to volcanic activity (1986) Archives of Environmental Health, 41, pp. 36-40
Baloch, Z.W., Mandel, S., LiVolsi, V.A., Combined tall cell carcinoma and Hurthle cell carcinoma (collision tumor) of the thyroid (2001) Archives of Pathology & Laboratory Medicine, 125, pp. 541-543
Barbara, D., Simi, U., Meucci, G., Lapi, P., Orsini, P., Pasquini, C., Thyroid papillary cancers: Microcarcinoma and carcinoma, incidental cancers and non-incidental cancers - are they different diseases? (2005) Clinical Endocrinology, 63, pp. 577-581
Begum, S., Rosenbaum, E., Henrique, R., Cohen, Y., Sidransky, D., Westra, W.H., BRAF mutations in anaplastic thyroid carcinoma: Implications for tumor origin, diagnosis and treatment (2004) Modern Pathology, 17, pp. 1359-1363
Belfiore, A., La Rosa, G.L., Padova, G., Sava, L., Ippolito, O., Vigneri, R., Prevalence of cold thyroid nodules and thyroid malignancies in patients from an iodine deficient area (1987) Cancer, 60, pp. 3096-3102
Ciampi, R., Knauf, J.A., Kerler, R., Gandhi, M., Zhu, Z., Nikiforova, M.N., Rabes, H.M., Nikiforov, Y.E., Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer (2005) Journal of Clinical Investigation, 115, pp. 94-101
Cimino, G., Toscano, G., Dissolution of trace metals from lava ash: Influence on the composition of rainwater in the Mount Etna volcanic area (1998) Environmental Pollution, 99, pp. 389-393
Colonna, M., Grosclaude, P., Remontet, L., Schvartz, C., Mace-Lesech, J., Velten, M., Guizard, A., Arveux, P., Incidence of thyroid cancer in adults recorded by French cancer registries (2002) European Journal of Cancer, 38, pp. 1762-1768
Comba, P., Gianfagna, A., Paoletti, L., Pleural mesothelioma cases in Biancavilla are related to a new fluoro-edenite fibrous amphibole (2003) Archives of Environmental Health, 58, pp. 229-232
Daum, G., Eisenmann-Tappe, I., Fries, H.W., Troppmair, J., Rapp, U.R., The ins and outs of Raf kinases (1994) Trends in Biochemical Sciences, 19, pp. 474-480
Delange, F., Vigneri, R., Trimarchi, F., Filetti, S., Pezzino, V., Squatrito, S., Bourdoux, P., Ermans, A.M., Etiological factors of endemic goiter in north-eastern Sicily (1978) Journal of Endocrinological Investigation, 1, pp. 137-142
Dobert N, Menzel C, Oeschger S & Grunwald F 2004 Differentiated thyroid carcinoma: the new UICC. 6th ed. TNM classification system in a retrospective analysis of 169 patients. Thyroid 14 65-70Durante, C., Puxeddu, E., Ferretti, E., Morisi, R., Moretti, S., Bruno, R., Barbi, F., Verrienti, A., BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism (2007) Journal of Clinical Endocrinology and Metabolism, 92, pp. 2840-2843
Fagin, J.A., Matsuo, K., Karmakar, A., Chen, D.L., Tang, S.H., Koeffler, H.P., High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas (1993) Journal of Clinical Investigation, 91, pp. 179-184
Farahati, J., Geling, M., Mader, U., Mortl, M., Luster, M., Muller, J.G., Flentje, M., Reiners, C., Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981-1995 (2004) Thyroid, 14, pp. 141-147
Fugazzola, L., Mannavola, D., Cirello, V., Vannucchi, G., Muzza, M., Vicentini, L., Beck-Peccoz, P., BRAF mutations in an Italian cohort of thyroid cancers (2004) Clinical Endocrinology, 61, pp. 239-243
Fugazzola, L., Puxeddu, E., Avenia, N., Romei, C., Cirello, V., Cavaliere, A., Faviana, P., Rossi, S., Correlation between BRAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: Data from a multicentric Italian study and review of the literature (2006) Endocrine-Related Cancer, 13, pp. 455-464
Garnett, M.J., Marais, R., Guilty as charged: BRAF is a human oncogene (2004) Cancer Cell, 6, pp. 313-319
Giannini, R., Ugolini, C., Lupi, C., Proietti, A., Elisei, R., Salvatore, G., Berti, P., Santoro, M., The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma (2007) Journal of Clinical Endocrinology and Metabolism, 92, pp. 3511-3516
Giordano, T.J., Kuick, R., Thomas, D.G., Misek, D.E., Vinco, M., Sanders, D., Zhu, Z., Shedden, K., Molecular classification of papillary thyroid carcinoma: Distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis (2005) Oncogene, 24, pp. 6646-6656
Gomez Segovia, I., Gallowitsch, H.J., Kresnik, E., Kumnig, G., Igerc, I., Matschnig, S., Stronegger, W.J., Lind, P., Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984-2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based age-stratified analysis on thyroid carcinoma incidence (2004) Thyroid, 14, pp. 277-286
Hernandez, B.Y., Highlights of recent cancer incidence data in Hawaii (2003) Hawaii Medical Journal, 62, pp. 17-18
Howe, H.L., Wingo, P.A., Thun, M.J., Ries, L.A., Rosenberg, H.M., Feigal, E.G., Edwards, B.K., Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends (2001) Journal of the National Cancer Institute, 93, pp. 824-842
Ito, Y., Uruno, T., Takamura, Y., Miya, A., Kobayashi, K., Matsuzuka, F., Kuma, K., Miyauchi, A., Papillary microcarcinomas of the thyroid with preoperatively detectable lymph node metastasis show significantly higher aggressive characteristics on immunohistochemical examination (2005) Oncology, 68, pp. 87-96
Ito, Y., Tomoda, C., Uruno, T., Takamura, Y., Miya, A., Kobayashi, K., Matsuzuka, F., Miyauchi, A., Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: Massive but not minimal extension affects the relapse-free survival (2006) World Journal of Surgery, 30, pp. 780-786
Jin, L., Sebo, T.J., Nakamura, N., Qian, X., Oliveira, A., Majerus, J.A., Johnson, M.R., Lloyd, R.V., BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid (2006) Diagnostic Molecular Pathology, 15, pp. 136-143
Jo, Y.S., Li, S., Song, J.H., Kwon, K.H., Lee, J.C., Rha, S.Y., Lee, H.J., Ro, H.K., Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer (2006) Journal of Clinical Endocrinology and Metabolism, 91, pp. 3667-3670
Kebebew, E., Weng, J., Bauer, J., Ranvier, G., Clark, O.H., Duh, Q.Y., Shibru, D., Griffin, A., The prevalence and prognostic value of BRAF mutation in thyroid cancer (2007) Annals of Surgery, 246, pp. 466-471
Kim, K.H., Kang, D.W., Kim, S.H., Seong, I.O., Kang, D.Y., Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population (2004) Yonsei Medical Journal, 45, pp. 818-821
Kim, T.Y., Kim, W.B., Song, J.Y., Rhee, Y.S., Gong, G., Cho, Y.M., Kim, S.Y., Shong, Y.K., The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma (2005) Clinical Endocrinology, 63, pp. 588-593
Kim, J., Giuliano, A.E., Turner, R.R., Gaffney, R.E., Umetani, N., Kitago, M., Elashoff, D., Hoon, D.S., Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma (2006) Annals of Surgery, 244, pp. 799-804
Knudsen, N., Laurberg, P., Perrild, H., Bulow, I., Ovesen, L., Jorgensen, T., Risk factors for goiter and thyroid nodules (2002) Thyroid, 12, pp. 879-888
Kolonel, L.N., Cancer incidence among Filipinos in Hawaii and the Philippines (1985) National Cancer Institute Monographs, 69, pp. 93-98
Lee, J.H., Lee, E.S., Kim, Y.S., Won, N.H., Chae, Y.S., BRAF mutation and AKAP9 expression in sporadic papillary thyroid carcinomas (2006) Pathology, 38, pp. 201-204
Leenhardt, L., Grosclaude, P., Cherie-Challine, L., Increased incidence of thyroid carcinoma in France: A true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee (2004) Thyroid, 14, pp. 1056-1060
Lin, J.D., Chen, S.T., Chao, T.C., Hsueh, C., Weng, H.F., Diagnosis and therapeutic strategy for papillary thyroid micro carcinoma (2005) Archives of Surgery, 140, pp. 940-945
Liu, R.T., Chen, Y.J., Chou, F.F., Li, C.L., Wu, W.L., Tsai, P.C., Huang, C.C., Cheng, J.T., No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan (2005) Clinical Endocrinology, 63, pp. 461-466
Lo, C.Y., Chan, W.F., Lang, B.H., Lam, K.Y., Wan, K.Y., Classical and follicular variant of papillary thyroid carcinoma: A comparative study on clinicopathologic features and long-term outcome (2006) World Journal of Surgery, 30, pp. 752-758
Lupi, C., Giannini, R., Ugolini, C., Proietti, A., Berti, P., Minuto, M., Materazzi, G., Miccoli, P., Association of BRAF V600E mutation with poor clinicopathologic outcomes in 500 consecutive cases of papillary thyroid carcinoma (2007) Journal of Clinical Endocrinology and Metabolism, 92, pp. 4085-4090
Maeta, H., Ohgi, S., Terada, T., Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas (2001) Virchows Archiv, 438, pp. 121-128
Melillo, R.M., Castellone, M.D., Guarino, V., De Falco, V., Cirafici, A.M., Salvatore, G., Caiazzo, F., Kruhoffer, M., The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells (2005) Journal of Clinical Investigation, 115, pp. 1068-1081
Mesa Jr, C., Mirza, M., Mitsutake, N., Sartor, M., Medvedovic, M., Tomlinson, C., Knauf, J.A., Fagin, J.A., Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodeling (2006) Cancer Research, 66, pp. 6521-6529
Mitsiades, C.S., Negri, J., McMullan, C., McMillin, D.W., Sozopoulos, E., Fanourakis, G., Voutsinas, G., Batt, D., Targeting BRAFV600E in thyroid carcinoma: Therapeutic implications (2007) Molecular Cancer Therapeutics, 6, pp. 1070-1078
Nakamura, N., Carney, J.A., Jin, L., Kajita, S., Pallares, J., Zhang, H., Qian, X., Lloyd, R.V., RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors (2005) Laboratory Investigation, 85, pp. 1065-1075
Namba, H., Nakashima, M., Hayashi, T., Hayashida, N., Maeda, S., Rogounovitch, T.I., Ohtsuru, A., Yamashita, S., Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers (2003) Journal of Clinical Endocrinology and Metabolism, 88, pp. 4393-4397
Nikiforov, Y.E., RET/PTC rearrangement in thyroid tumors (2002) Endocrine Pathology, 13, pp. 3-16
Nikiforov, Y.E., Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas (2004) Endocrine Pathology, 15, pp. 319-327
Nikiforova, M.N., Kimura, E.T., Gandhi, M., Biddinger, P.W., Knauf, J.A., Basolo, F., Zhu, Z., Fusco, A., BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas (2003) Journal of Clinical Endocrinology and Metabolism, 88, pp. 5399-5404
Nikiforova, M.N., Ciampi, R., Salvatore, G., Santoro, M., Gandhi, M., Knauf, J.A., Thomas, G.A., Tronko, M.D., Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas (2004) Cancer Letters, 209, pp. 1-6
Oler, G., Ebina, K.N., Michaluart Jr, P., Kimura, E.T., Cerutti, J., Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis reveals a new mutation in metastasis (2005) Clinical Endocrinology, 62, pp. 509-511
Palona, I., Namba, H., Mitsutake, N., Starenki, D., Podtcheko, A., Sedliarou, I., Ohtsuru, A., Umezawa, K., BRAF V600E promotes invasiveness of thyroid cancer cells through nuclear factor κB activation (2006) Endocrinology, 147, pp. 5699-5707
Park, S.Y., Park, Y.J., Lee, Y.J., Lee, H.S., Choi, S.H., Choe, G., Jang, H.C., Cho, B.Y., Analysis of differential BRAF(V600E) mutational status in multifocal papillary thyroid carcinoma: Evidence of independent clonal origin in distinct tumor foci (2006) Cancer, 107, pp. 1831-1838
Pelizzo, M.R., Boschin, I.M., Toniato, A., Pagetta, C., Piotto, A., Bernante, P., Casara, D., Rubello, D., Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): A mono-institutional 12-year experience (2004) Nuclear Medicine Communications, 25, pp. 547-552
Pellegriti, G., Scollo, C., Lumera, G., Regalbuto, C., Vigneri, R., Belfiore, A., Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: Study of 299 cases (2004) Journal of Clinical Endocrinology and Metabolism, 89, pp. 3713-3720
Penko, K., Livezey, J., Fenton, C., Patel, A., Nicholson, D., Flora, M., Oakley, K., Francis, G., BRAF mutations are uncommon in papillary thyroid cancer of young patients (2005) Thyroid, 15, pp. 320-325
Peyssonnaux, C., Eychene, A., The Raf/MEK/ERK pathway: New concepts of activation (2001) Biology of the Cell, 93, pp. 53-62
Powell, N., Jeremiah, S., Morishita, M., Dudley, E., Bethel, J., Bogdanova, T., Tronko, M., Thomas, G., Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation exposure (2005) Journal of Pathology, 205, pp. 558-564
Puxeddu, E., Moretti, S., Giannico, A., Martinelli, M., Marino, C., Avenia, N., Cristofani, R., Ribacchi, R., Ret/PTC activation does not influence clinical and pathological features of adult papillary thyroid carcinomas (2003) European Journal of Endocrinology, 148, pp. 505-513
Quiros, R.M., Ding, H.G., Gattuso, P., Prinz, R.A., Xu, X., Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations (2005) Cancer, 103, pp. 2261-2268
Regalbuto, C., Squatrito, S., La Rosa, G.L., Cercabene, G., Ippolito, A., Tita, P., Salamone, S., Vigneri, R., Longitudinal study on goiter prevalence and goitrogen factors in northeastern Sicily (1996) Journal of Endocrinological Investigation, 19, pp. 638-645
Riesco-Eizaguirre, G., Gutierrez-Martinez, P., Garcia-Cabezas, M.A., Nistal, M., Santisteban, P., The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I- targeting to the membrane (2006) Endocrine-Related Cancer, 13, pp. 257-269
Rodolico, V., Cabibi, D., Pizzolanti, G., Richiusa, P., Gebbia, N., Martorana, A., Russo, A., Giordano, C., BRAF(V600E) mutation and p27(kip1) expression in papillary carcinomas of the thyroid 1 cm and their paired lymph node metastases (2007) Cancer, 110, pp. 1218-1226
Rosenbaum, E., Hosler, G., Zahurak, M., Cohen, Y., Sidransky, D., Westra, W.H., Mutational activity of BRAF is not a major event in sporadic childhood papillary thyroid carcinoma (2005) Modern Pathology, 18, pp. 898-902
Santoro, M., Carlomagno, F., Hay, I.D., Herrmann, M.A., Grieco, M., Melillo, R., Pierotti, M.A., Berger, N., Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype (1992) Journal of Clinical Investigation, 89, pp. 1517-1522
Santoro, M., Melillo, R.M., Carlomagno, F., Fusco, A., Vecchio, G., Molecular mechanisms of RET activation in human cancer (2002) Annals of the New York Academy of Sciences, 963, pp. 116-121
Santoro, M., Papotti, M., Chiappetta, G., Garcia-Rostan, G., Volante, M., Johnson, C., Camp, R.L., Herrero, A., RET activation and clinicopathologic features in poorly differentiated thyroid tumors (2002) Journal of Clinical Endocrinology and Metabolism, 87, pp. 370-379
Sapio, M.R., Posca, D., Troncone, G., Pettinato, G., Palombini, L., Rossi, G., Fenzi, G., Vitale, M., Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA) (2006) European Journal of Endocrinology, 154, pp. 341-348
Sedliarou, I., Saenko, V., Lantsov, D., Rogounovitch, T., Namba, H., Abrosimov, A., Lushnikov, E., Meirmanov, S., The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma (2004) International Journal of Oncology, 25, pp. 1729-1735
Tronko, M.D., Howe, G.R., Bogdanova, T.I., Bouville, A.C., Epstein, O.V., Brill, A.B., Likhtarev, I.A., Greenebaum, E., A cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident: Thyroid cancer in Ukraine detected during first screening (2006) Journal of the National Cancer Institute, 98, pp. 897-903
Trovisco, V., Vieira de Castro, I., Soares, P., Maximo, V., Silva, P., Magalhaes, J., Abrosimov, A., Sobrinho-Simoes, M., BRAF mutations are associated with some histological types of papillary thyroid carcinoma (2004) Journal of Pathology, 202, pp. 247-251
Trovisco, V., Soares, P., Preto, A., de Castro, I.V., Lima, J., Castro, P., Maximo, V., Meireles, A.M., Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness (2005) Virchows Archiv, 446, pp. 589-595
Vasko, V., Ferrand, M., Di Cristofaro, J., Carayon, P., Henry, J.F., de Micco, C., Specific pattern of RAS oncogene mutations in follicular thyroid tumors (2003) Journal of Clinical Endocrinology and Metabolism, 88, pp. 2745-2752
Vasko, V., Hu, S., Wu, G., Xing, J.C., Larin, A., Savchenko, V., Trink, B., Xing, M., High prevalence and possible de novo formation of BRAF mutation in metastasized papillary thyroid cancer in lymph nodes (2005) Journal of Clinical Endocrinology and Metabolism, 90, pp. 5265-5269
Vigneri, R., Studies on the goiter endemia in Sicily (1988) Journal of Endocrinological Investigation, 11, pp. 831-843
Xing, M., BRAF mutation in thyroid cancer (2005) Endocrine-Related Cancer, 12, pp. 245-262
Xing, M., Westra, W.H., Tufano, R.P., Cohen, Y., Rosenbaum, E., Rhoden, K.J., Carson, K.A., Tallini, G., BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer (2005) Journal of Clinical Endocrinology and Metabolism, 90, pp. 6373-6379
Zwi, L.J., LiVolsi, V.A., Hurthle cell carcinoma arising from thyroid papillary carcinoma (2002) Endocrine Pathology, 13, pp. 213-217
Akslen, L. A., Haldorsen, T., Thoresen, S. O., Glattre, E., Incidence pattern of thyroid cancer in Norway: Influence of birth cohort and time period (1993) International Journal of Cancer, 53, pp. 183-187
Baloch, Z. W., Mandel, S., LiVolsi, V. A., Combined tall cell carcinoma and Hurthle cell carcinoma (collision tumor) of the thyroid (2001) Archives of Pathology & Laboratory Medicine, 125, pp. 541-543
Fagin, J. A., Matsuo, K., Karmakar, A., Chen, D. L., Tang, S. H., Koeffler, H. P., High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas (1993) Journal of Clinical Investigation, 91, pp. 179-184
Garnett, M. J., Marais, R., Guilty as charged: BRAF is a human oncogene (2004) Cancer Cell, 6, pp. 313-319
Giordano, T. J., Kuick, R., Thomas, D. G., Misek, D. E., Vinco, M., Sanders, D., Zhu, Z., Shedden, K., Molecular classification of papillary thyroid carcinoma: Distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis (2005) Oncogene, 24, pp. 6646-6656
Hernandez, B. Y., Highlights of recent cancer incidence data in Hawaii (2003) Hawaii Medical Journal, 62, pp. 17-18
Howe, H. L., Wingo, P. A., Thun, M. J., Ries, L. A., Rosenberg, H. M., Feigal, E. G., Edwards, B. K., Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends (2001) Journal of the National Cancer Institute, 93, pp. 824-842
Jin, L., Sebo, T. J., Nakamura, N., Qian, X., Oliveira, A., Majerus, J. A., Johnson, M. R., Lloyd, R. V., BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid (2006) Diagnostic Molecular Pathology, 15, pp. 136-143
Jo, Y. S., Li, S., Song, J. H., Kwon, K. H., Lee, J. C., Rha, S. Y., Lee, H. J., Ro, H. K., Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer (2006) Journal of Clinical Endocrinology and Metabolism, 91, pp. 3667-3670
Kim, K. H., Kang, D. W., Kim, S. H., Seong, I. O., Kang, D. Y., Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population (2004) Yonsei Medical Journal, 45, pp. 818-821
Kim, T. Y., Kim, W. B., Song, J. Y., Rhee, Y. S., Gong, G., Cho, Y. M., Kim, S. Y., Shong, Y. K., The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma (2005) Clinical Endocrinology, 63, pp. 588-593
Kolonel, L. N., Cancer incidence among Filipinos in Hawaii and the Philippines (1985) National Cancer Institute Monographs, 69, pp. 93-98
Lee, J. H., Lee, E. S., Kim, Y. S., Won, N. H., Chae, Y. S., BRAF mutation and AKAP9 expression in sporadic papillary thyroid carcinomas (2006) Pathology, 38, pp. 201-204
Lin, J. D., Chen, S. T., Chao, T. C., Hsueh, C., Weng, H. F., Diagnosis and therapeutic strategy for papillary thyroid micro carcinoma (2005) Archives of Surgery, 140, pp. 940-945
Liu, R. T., Chen, Y. J., Chou, F. F., Li, C. L., Wu, W. L., Tsai, P. C., Huang, C. C., Cheng, J. T., No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan (2005) Clinical Endocrinology, 63, pp. 461-466
Lo, C. Y., Chan, W. F., Lang, B. H., Lam, K. Y., Wan, K. Y., Classical and follicular variant of papillary thyroid carcinoma: A comparative study on clinicopathologic features and long-term outcome (2006) World Journal of Surgery, 30, pp. 752-758
Melillo, R. M., Castellone, M. D., Guarino, V., De Falco, V., Cirafici, A. M., Salvatore, G., Caiazzo, F., Kruhoffer, M., The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells (2005) Journal of Clinical Investigation, 115, pp. 1068-1081
Mitsiades, C. S., Negri, J., McMullan, C., McMillin, D. W., Sozopoulos, E., Fanourakis, G., Voutsinas, G., Batt, D., Targeting BRAFV600E in thyroid carcinoma: Therapeutic implications (2007) Molecular Cancer Therapeutics, 6, pp. 1070-1078
Nikiforov, Y. E., RET/PTC rearrangement in thyroid tumors (2002) Endocrine Pathology, 13, pp. 3-16
Nikiforov, Y. E., Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas (2004) Endocrine Pathology, 15, pp. 319-327
Nikiforova, M. N., Kimura, E. T., Gandhi, M., Biddinger, P. W., Knauf, J. A., Basolo, F., Zhu, Z., Fusco, A., BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas (2003) Journal of Clinical Endocrinology and Metabolism, 88, pp. 5399-5404
Park, S. Y., Park, Y. J., Lee, Y. J., Lee, H. S., Choi, S. H., Choe, G., Jang, H. C., Cho, B. Y., Analysis of differential BRAF (V600E) mutational status in multifocal papillary thyroid carcinoma: Evidence of independent clonal origin in distinct tumor foci (2006) Cancer, 107, pp. 1831-1838
Pelizzo, M. R., Boschin, I. M., Toniato, A., Pagetta, C., Piotto, A., Bernante, P., Casara, D., Rubello, D., Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): A mono-institutional 12-year experience (2004) Nuclear Medicine Communications, 25, pp. 547-552
Quiros, R. M., Ding, H. G., Gattuso, P., Prinz, R. A., Xu, X., Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations (2005) Cancer, 103, pp. 2261-2268
Sapio, M. R., Posca, D., Troncone, G., Pettinato, G., Palombini, L., Rossi, G., Fenzi, G., Vitale, M., Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA) (2006) European Journal of Endocrinology, 154, pp. 341-348
Tronko, M. D., Howe, G. R., Bogdanova, T. I., Bouville, A. C., Epstein, O. V., Brill, A. B., Likhtarev, I. A., Greenebaum, E., A cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident: Thyroid cancer in Ukraine detected during first screening (2006) Journal of the National Cancer Institute, 98, pp. 897-903
Zwi, L. J., LiVolsi, V. A., Hurthle cell carcinoma arising from thyroid papillary carcinoma (2002) Endocrine Pathology, 13, pp. 213-217
BRAF(V600E) mutation and the biology of papillary thyroid cancer